Antimicrobial susceptibility patterns and high-level gentamicin resistance among enterococci isolated in a Mexican tertiary care center

Revista de Investigacion Clinica

Volumn 48, Issue 2, 1996, Pages 91-96

  Sifuentes Osornio, José ^a   Ponce De León, Alfredo ^a   Muñoz Trejo, Teresa ^a   Villalobos Zapata, Yvonne ^a   Ontiveros Rodríguez, Consuelo ^a   Cómez Roldán, Carlos ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

antimicrobial susceptibility; enterococcal infections; Enterococcus; high level gentamicin resistant enterococci

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; KANAMYCIN; NORFLOXACIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; ENTEROCOCCUS; HUMAN; MINIMUM INHIBITORY CONCENTRATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GENTAMICINS; HUMANS; MEXICO; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES;

EID: 0030001451     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bryce EA, Zemcov SJV, Clarke AM. Species identification and antibiotic resistance patterns of the enterococci. Eur J Clin Microbiol Infect Dis 1991;10:745-7.
2. Morrison AJ Jr, Wenzel RP. Nosocomial urinary tract infections due to enterococcus. Arch Intern Med 1986; 105:1549-51.
3. Eliopoulos CM, Eliopoulos CT. Therapy of enterococcal infections. Eur J Clin Microbiol Infect Dis 1990;9:118-26.
4. Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RM, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:2373-8.
5. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 1988;67:248-68.
6. Sifuentes-Osornio J, Macías A, Amieva RI, Ramos A, Ruiz-Palacios GM. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective controlled trial with a third party blinding. Am J Med 1989;87(Suppl):202-5.
7. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-4.
8. Jorgensen JH, Cleeland R, Craig WA. Performance standards for antimicrobial susceptibility testing. NCCLS Document M100-S3. Third Informational Supplement 1991:11-7.
9. Lemoine L, Hunter RP. Enterococcal urinary tract infections in a teaching hospital. Eur J Clin Microbiol Infect Dis 1987;6:574-5.
10. Gómez-Roldán CI, Sifuentes-Osornio J, Calva JJ, Villalobos Y, Muñoz T, Ontiveros C. Antimicrobial resistance profile of clinical isolates of enterococci in a tertiary care center. In: American Society for Microbiology, Program 32nd Interscience Conference Antimicrobial Agents Chemotherapy, 1992:1176.
11. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;1:46-65.
12. Lewis CM, Zervos MJ. Clinical manifestations of enterococcal infection. Eur J Clin Microbiol Infect Dis 1990;9:111-7.
13. Chenoweth C, Schaberg D. The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis 1990;9:80-9.
14. Merquior VLC, Stern CS, Carvalho MGS, Teixeira LM. Prevalence of high-level-resistance to gentamicin among enterococci in Brazil. In: American Society for Microbiology. Program 32nd General Meeting 1992:C-259.
15. Sahm DF, Boonlayangoor S, Schulz JE. Detection of high-level aminoglycoside resistance in enterococci other than E. faecalis. J Clin Microbiol 1991;29:2595-8.
16. Nosocomial Infectious Surveillance 1984. CDC surveillance summaries. MMWR 1986;35(1SS):17SS-29SS.
17. Gullgerg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989;11:74-85.
18. Moellering RC Jr. The enterococci: an enigma and a continuing therapeutic challenge. Eur J Clin Microbiol Infect Dis 1990;9:73-4.
19. Abdelhady E, Mortensen JE. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium. Diag Microbiol Infect Dis 1991;14:141-5.
20. Murray BE. Changing resistance patterns in enterococci. In: American Society for Microbiology. Program 30th Interscience Conference on Antimicrobial Agents and Chemotherapy 1990:329.
21. Oster SE, Chirugi VA, Goldberg AA, Aiken S, McCabe RE. Ampicillin-resistant enterococcal species in an acute-care hospital. Antimicrob Agent Chemother 1990;34:1521-3.
22. Bush LM, Calmon J, Cherney CL, Wendeler M, Pitsakis P, Poupard J, et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med 1989;110:515-20.
23. Nicas TI, Wu CYE, Hobbs JN, Preston DA, Allen NE. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agent Chemother 1989;33:1121-4.
24. Johnson AP, Uttley AH, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev 1990;3:280-91.
25. Ruoff KL, De la Maza L, Murtagh MJ. Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 1990;28:435-7.